Anika Therapeutics
ANIK
172 hedge funds and large institutions have $670M invested in Anika Therapeutics in 2017 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 65 increasing their positions, 54 reducing their positions, and 16 closing their positions.
44% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 16
20% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 54
4% more funds holding
Funds holding: 166 → 172 (+6)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.19% less ownership
Funds ownership: 84.91% → 84.72% (-0.19%)
8% less capital invested
Capital invested by funds: $726M → $670M (-$55.9M)
Top Buyers
| 1 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
+$3.37M |
| 2 |
BlackRock
New York
|
+$3.22M |
| 3 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
+$1.42M |
| 4 |
HSA
Hussman Strategic Advisors
Ellicott City,
Maryland
|
+$1.38M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.21M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BCM
176
BlueCrest Capital Management
St Helier,
Jersey
| – | -$516K | -8,896 | Closed |
|
|
AP
177
AHL Partners
London,
United Kingdom
| – | -$458K | -7,890 | Closed |
|
178
Simplex Trading
Chicago,
Illinois
| – | -$328K | -5,931 | Closed |
|
|
CONA
179
Capital One National Association
New York
| – | -$342K | -5,896 | Closed |
|
|
AI
180
Atria Investments
Charlotte,
North Carolina
| – | -$289K | -4,986 | Closed |
|
181
Wolverine Trading
Chicago,
Illinois
| – | -$226K | -3,896 | Closed |
|
|
NIT
182
NumerixS Investment Technologies
Vancouver,
British Columbia, Canada
| – | -$139K | -2,400 | Closed |
|
183
SG Americas Securities
New York
| – | -$118K | -2,041 | Closed |
|
|
CG
184
Cutler Group
San Francisco,
California
| – | -$58K | -1,000 | Closed |
|
|
TSW
185
Thompson Siegel & Walmsley
Richmond,
Virginia
| – | -$4K | -66 | Closed |
|
|
FHA
186
First Horizon Advisors
Memphis,
Tennessee
| – | -$3K | -61 | Closed |
|
|
DCM
187
Delpha Capital Management
New York
| – | +$166 | +3 | New |
|
188
AssetMark Inc
Concord,
California
| – | +$277 | +5 | New |
|
ANIK Hedge Fund Activity: Q4 2017 in Review
172 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Anika Therapeutics (ANIK) for Q4 2017, worth a combined $670M — down 7.7% from $726M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new ANIK positions and 16 closed out — a net gain of 7 holders — while 65 added to existing stakes and 54 trimmed.
The largest buyer was Columbia Wanger Asset Management, adding an estimated $3.37M. The largest seller was Polar Asset Management Partners, exiting entirely with an estimated $6.14M sold.
- 172 institutional investors held Anika Therapeutics (ANIK) as of Q4 2017, up from 166 in Q3 2017.
- Funds reported $670M of Anika Therapeutics stock for Q4 2017, down 7.7% quarter-over-quarter.
- 23 funds opened new Anika Therapeutics positions in Q4 2017 and 16 closed out, a net change of +7 holders.
- The largest Anika Therapeutics buyer in Q4 2017 was Columbia Wanger Asset Management, an estimated $3.37M added.
- The largest Anika Therapeutics seller in Q4 2017 was Polar Asset Management Partners, an estimated $6.14M sold.
Based on aggregated 13F filings for Q4 2017.